Prograf · DIN 02243144 · 0.5 mg · capsule
Limited Use, Reason for Use code 173 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 173 required
Write on scriptReason for Use code 173 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 173
Reason for Use code 173
For solid organ transplant and bone marrow transplant.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: innoviCares lists Prograf (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Prograf · DIN 02243144
Manufacturer: Astellas Pharma Canada Inc.; listing date 2009-04-01
Health Canada: Marketed since 2005-11-07 · brand PROGRAF · ATC L04AD02 TACROLIMUS · form Capsule · route Oral · ingredients TACROLIMUS 0.5 MG · company Astellas pharma canada inc · schedule Prescription
Ministry pays: $1.0146 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243144)
Source record
DIN 02243144: Prograf
Raw flags: sec12=Y, sec3=Y
Item: 920000391; group id 966; item number 2292; lccId 00137; manufacturer id ASE
Source form: Cap; strength: 0.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.0291; ministry $1.0146
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243144
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67015
Interchangeable products
Ach-Tacrolimus · DIN 02454068 · $1.0146
Sandoz Tacrolimus · DIN 02416816 · $1.0146
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02243144
Shortage record checked October 6, 2026